Leading The Genomic Medicine Revolution

Genomic medicine enables us to treat human biology in a digital way, and rapidly develop drugs at a population basis and at an individual level. We work with the world’s leading drug developers to understand disease and create the therapeutics and vaccines that will define the future of medicine. PNI’s NanoAssemblr^® microfluidic instruments, GenVoy™ lipid nanoparticle delivery reagents, and Biopharmaceutical Services enable researchers to translate disease biology insights into non-viral genomic medicines.